Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT02737956
Eligibility Criteria:
Inclusion Criteria:
Acute myocardial infarction patients in hospitalized of the First Affiliated Hospital of Xinjiang Medical University (include diagnosed acute ST-elevation or non ST-elevation myocardial infarction).Diagnosis criteria must meet Universal Definition for AMI (2012).
Exclusion Criteria:
1. Combined with severe valvular heart disease;
2. Combined with severe congenital heart disease;
3. Combined hyperthyroidism, anemia and other high-powered heart disease;
4. With pulmonary heart disease;
5. With hypertrophic obstructive cardiomyopathy;
6. Severe hypotension (SBP \<90mmHg or DBP \<60mmHg at enrollment);
7. Uncontrolled hypertension (SBP\> 160 mmHg before PCI, and / or DBP\> 100 mmHg);
8. Liver dysfunction (defined as ALT or total bilirubin is greater than the normal upper limit of 3 times);
9. Renal insufficiency (defined as serum creatinine greater than 1.5 times the normal upper limit);
10. High-risk bleeding patients, such as thrombocytopenia, blood diseases and other diseases;
11. active peptic ulcer and skin ulcers;
12. A patient who is allergic to clopidogrel, tegrellol, or aspirin;
13. Patients with a history of cardiogenic shock within two weeks;
14. pregnant and lactating women, during treatment can not be strict contraception of women of childbearing age;
15. In the past 3 months participated in other clinical researchers;
16. Persons who do not have legal or legal competence;
17. Any condition that the investigator considers unsuitable for participation in the clinical study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
79 Years
Study:
NCT02737956
Study Brief:
Protocol Section:
NCT02737956